KIZOO Technology Capital is a venture capital firm based in Karlsruhe, Germany, focused on rejuvenation biotech and longevity startups. Founded by Michael Greve, the firm provides seed and early-stage financing to companies developing therapies addressing the root causes of aging, with historical investments also in internet and SaaS.
50% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $11.2M (across 6 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
FS
Frank Schueler
Managing Director
JC
Junki Cho
CEO
MG
Michael Greve
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 MoglingBio | Seed | — | Oct 2022 |
 Elevian | Series A | $15M | Nov 2020 |
 Staffbase | Series C | $23M | Jul 2019 |
| Staffbase | Unknown | $12M | Jan 2019 |
 shyftplan | Series A | — | Oct 2017 |
 Suitepad | Seed | $3.3M | Feb 2016 |
 Reservoir Neuroscience | Unknown | $4M | — |
 Elastrin | Unknown | $10M | — |
Top Co-Investors
Capnamic Ventures2 shared
Headline2 shared
Insight Partners2 shared
Target Global1 shared
Andera Partners1 shared
Bold Capital Partners1 shared
Western Technology Investment1 shared
The Longevity Fund1 shared
Prime Movers Lab1 shared
UnternehmerTUM1 shared
UVC Partners1 shared
coparion1 shared
Senovo1 shared
Dolby Family Ventures1 shared
Starbloom Capital1 shared
Last updated: 14 September 2026